Age-adjusted lung cancer mortality in the United States is estimated to decrease by 79 percent between 2015 and 2065, according to a new study published in the Annals of Internal Medicine. However, the authors noted, millions of lung cancer deaths are still projected during that time, making it especially important to emphasize screening in the years ahead.